Amazon expands AI chip strategy while entering weight-loss drug market, sparking shareholder governance debates

CEO Andy Jassy announced Amazon will sell proprietary AI chips alongside major industry suppliers, signaling deeper vertical integration into cloud infrastructure

Amazon Pharmacy now offers Eli Lilly's Foundayo weight-loss pill with same-day delivery, marking a significant expansion into direct-to-consumer healthcare

Multiple shareholder proposals on climate and governance issues were filed ahead of Amazon's annual meeting, intensifying ESG scrutiny